En español
NIDA

Menu

Panel Members: Boston, MA Location, March 2011

Long Day's Journey into Night

By Eugene O'Neill

Harvard location Panel Members:

Daniel Alford, MD

Dr. Daniel Alford, MD, MPH, FACP, FASAM, is an associate professor of Medicine at Boston University School of Medicine and is on staff in the Section of General Internal Medicine, Clinical Addiction Research and Education Unit at Boston Medical Center (BMC). He is certified in Addiction Medicine by the American Board of Addiction Medicine. He serves as the medical director of the Massachusetts Screening, Brief Intervention, Referral and Treatment (MASBIRT) program and the BMC Office-based Opioid Treatment program. He serves as a national mentor for the SAMHSA Physician Clinical Support Systems (PCSS) for buprenorphine and clinical expert for the PCSS for methadone in the treatment of pain and opioid addiction. He co-chairs the American Society of Addiction Medicine (ASAM) committees on Opioid Agonist Treatment and Buprenorphine Training. He directs the NIDA funded Chief Resident Immersion Training Program - Addiction Medicine: Improving Clinical and Teaching Skills for Generalists. He is on the executive board of the Association of Medical Education in Research in Substance Abuse (AMERSA).

Brian Jack, MD

Brian Jack, MD, is Professor and Vice Chair for Academic Affairs in the Department of Family Medicine at Boston University School of Medicine / Boston Medical Center. Dr. Jack graduated from the University of Massachusetts Medical School and completed his residency training at the Brown University. He completed a fellowship at the University of Washington.

Dr. Jack has authored over 90 peer reviewed papers or book chapters, and is PI on grants from HRSA, CDC, AHRQ, NHLBI and HRSA.

For his work relating to improving patient safety at hospital discharge (Project RED), he received the "Excellence in Patent Education Innovation" and the AHRQ "Patient Safety Investigator of the Month". In 2009, he was selected as one of 20 nationally to HealthLeaders magazine's "People Who Make Healthcare Better" list. He has also received the CDC "Partner in Public Health Improvement" award (only one award is given to an individual outside the CDC each year), and was listed as among "Boston's Best Doctors" for 2010.

Dr. Jack is clinical director of a Kellogg Foundation funded program in Lesotho that aims to improve the quality of district health services and where he has initiated a family medicine training program. He has served as a consultant to USAID, the World Bank, the US Department of State and the Rockefeller foundation on the development of primary care in Lesotho, Hungary, Albania, Jordan, Romania, and Vietnam.

Janice Kauffman, RN MPH

Janice F. Kauffman RN, MPH, is vice president of Addiction Treatment Services for North Charles Foundation, Inc., Addiction Consultation for the Department of Psychiatry, Cambridge Health Alliance, and Assistant Professor of Psychiatry, Harvard Medical School, the Cambridge Hospital. She was the director of the Addiction Psychiatry Service, Brigham and Women's Hospital from 1991to 2009. She has worked with addictive disorders for the past 38 years in direct treatment, program development and management, teaching, and local and national policy initiatives. She is the founder and president of the Massachusetts Methadone Treatment Providers Association, and the Massachusetts delegate and first vice president to the American Association for the Treatment of Opioid Dependence Board of Directors. Areas of expertise include opioid dependence, addicted medical professors, dual diagnosis, pain and addiction, and addictions in general hospitals.

Shonali Saha, MD

Born in St. Louis, Dr. Shonali Saha majored in African American Studies at Columbia University with an emphasis on The War on Drugs and its impact on Black families. Before medical school, she also worked as an HIV/AIDS and substance abuse/harm reduction counselor and trainer both in New York and India. During medical school at Mount Sinai, her interests developed in community based participatory research and adolescent medicine. She is currently a primary care/internal medicine resident at the Cambridge Health Alliance. After graduation from residency in July 2011, she will be starting an Adolescent Medicine Fellowship at Johns Hopkins.

Paramount loc​ation Panel Members:

Daniel Alford, MD

Dr. Daniel Alford, MD, MPH, FACP, FASAM, is an associate professor of Medicine at Boston University School of Medicine and is on staff in the Section of General Internal Medicine, Clinical Addiction Research and Education Unit at Boston Medical Center (BMC). He is certified in Addiction Medicine by the American Board of Addiction Medicine. He serves as the medical director of the Massachusetts Screening, Brief Intervention, Referral and Treatment (MASBIRT) program and the BMC Office-based Opioid Treatment program. He serves as a national mentor for the SAMHSA Physician Clinical Support Systems (PCSS) for buprenorphine and clinical expert for the PCSS for methadone in the treatment of pain and opioid addiction. He co-chairs the American Society of Addiction Medicine (ASAM) committees on Opioid Agonist Treatment and Buprenorphine Training. He directs the NIDA funded Chief Resident Immersion Training Program - Addiction Medicine: Improving Clinical and Teaching Skills for Generalists. He is on the executive board of the Association of Medical Education in Research in Substance Abuse (AMERSA).

Brian Jack, MD

Brian Jack, MD, is Professor and Vice Chair for Academic Affairs in the Department of Family Medicine at Boston University School of Medicine / Boston Medical Center. Dr. Jack graduated from the University of Massachusetts Medical School and completed his residency training at the Brown University. He completed a fellowship at the University of Washington.

Dr. Jack has authored over 90 peer reviewed papers or book chapters, and is PI on grants from HRSA, CDC, AHRQ, NHLBI and HRSA.

For his work relating to improving patient safety at hospital discharge (Project RED), he received the "Excellence in Patent Education Innovation" and the AHRQ "Patient Safety Investigator of the Month". In 2009, he was selected as one of 20 nationally to HealthLeaders magazine's "People Who Make Healthcare Better" list. He has also received the CDC "Partner in Public Health Improvement" award (only one award is given to an individual outside the CDC each year), and was listed as among "Boston's Best Doctors" for 2010.

Dr. Jack is clinical director of a Kellogg Foundation funded program in Lesotho that aims to improve the quality of district health services and where he has initiated a family medicine training program. He has served as a consultant to USAID, the World Bank, the US Department of State and the Rockefeller foundation on the development of primary care in Lesotho, Hungary, Albania, Jordan, Romania, and Vietnam.

Janice Kauffman, RN MPH

Janice F. Kauffman RN, MPH, is vice president of Addiction Treatment Services for North Charles Foundation, Inc., Addiction Consultation for the Department of Psychiatry, Cambridge Health Alliance, and Assistant Professor of Psychiatry, Harvard Medical School, the Cambridge Hospital. She was the director of the Addiction Psychiatry Service, Brigham and Women's Hospital from 1991to 2009. She has worked with addictive disorders for the past 38 years in direct treatment, program development and management, teaching, and local and national policy initiatives. She is the founder and president of the Massachusetts Methadone Treatment Providers Association, and the Massachusetts delegate and first vice president to the American Association for the Treatment of Opioid Dependence Board of Directors. Areas of expertise include opioid dependence, addicted medical professors, dual diagnosis, pain and addiction, and addictions in general hospitals.

Sherry Nykiel, MD

Dr. Sherry Nykiel is board-certified in psychiatry and completed the Partners Addiction Psychiatry fellowship in Boston, MA. She is medical director at The McLean Center at Fernside and Instructor of psychiatry at Harvard Medical School. Dr. Nykiel has special interest in developing innovative, evidence-based psychosocial treatments for dual diagnosis populations and is currently a McLean Hospital Maria Lorenz Pope Research Fellow studying a novel integrated treatment for patients with co-occurring borderline personality disorder and substance use disorders. In addition to clinical teaching, she is editor of The Massachusetts General Hospital and McLean Hospital Residency Handbook of Psychiatry (2010), designer of a flexible curriculum to train clinicians in the effective use of Alcoholics Anonymous as an adjunct for patients with alcohol use disorders, and a trainer for buprenorphine prescribing.